Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Current Pharmaceutical Design|July 29, 2004
A(1) adenosine receptor agonists: medicinal chemistry and therapeutic potentialS A Hutchinson, P J ScammellsCurrent Medicinal Chemistry|February 19, 2014
The dopamine D2 and adenosine A2A receptors: past, present and future trends for the treatment of Parkinson's diseaseM Jorg, P J Scammells, B CapuanoBritish Journal of Pharmacology|July 6, 2000
Differential A(1)-adenosine receptor reserve for inhibition of cyclic AMP accumulation and G-protein activation in DDT(1) MF-2 cellsS P Baker, P J Scammells, L BelardinelliBioorganic & Medicinal Chemistry Letters|March 7, 2001
Photochemical N-demethylation of alkaloidsJ A Ripper, E R Tiekink, P J ScammellsJournal of Medicinal Chemistry|September 1, 1991
Synthesis and adenosine receptor affinity of a series of pyrazolo[3,4-d]pyrimidine analogues of 1-methylisoguanosineF A Harden, R J Quinn, P J ScammellsBioorganic & Medicinal Chemistry|November 5, 1998
XH-14 analogues as adenosine antagonistsP J Scammells, S P Baker, A R BeaugleholeJournal of Medicinal Chemistry|January 11, 2001
Fluorosulfonyl-substituted xanthines as selective irreversible antagonists for the A(1)-adenosine receptorA R Beauglehole, S P Baker, P J ScammellsBioorganic & Medicinal Chemistry Letters|May 7, 1999
Adenosine receptor ligands with oxygenated N6-substituentsS A Hutchinson, S P Baker, P J ScammellsJournal of Medicinal Chemistry|August 19, 1994
Substituted 1,3-dipropylxanthines as irreversible antagonists of A1 adenosine receptorsP J Scammells, S P Baker, L Belardinelli, et al.Bioorganic & Medicinal Chemistry Letters|February 6, 1999
N6-(5,6-epoxynorbornyl)adenosine analogs as A1 adenosine agonistsD M Wright, S P Baker, S G Stewart, et al.Pageof 2